Refine your search
Collections
Co-Authors
Journals
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Kote, Rahul
- Comparative Study of Efficacy of Glycolic Acid Peel and Intense Pulsed Light in the Treatment of Melasma
Abstract Views :309 |
PDF Views:132
Authors
Affiliations
1 Department of Dermatology, Venerology and Leprology, Dr. Vasantrao Pawar Medical College, Hospital, and Research Centre, Vasantdada Nagar, Adgaon, Nashik-422003, IN
1 Department of Dermatology, Venerology and Leprology, Dr. Vasantrao Pawar Medical College, Hospital, and Research Centre, Vasantdada Nagar, Adgaon, Nashik-422003, IN
Source
MVP Journal of Medical Sciences, Vol 2, No 1 (2015), Pagination: 39-48Abstract
Background: Melasma, one of the common aesthetically displeasing entities, continues to be a difficult problem to treat. Chemical peeling is one new weapon in the therapeutic armamentarium of melasma. Intense Pulsed Light (IPL) is a noncoherent, broad-spectrum light, ranging from 500 to 1200 nm. Intense Pulsed Light (IPL) treatment is a good option for patients with melasma. Aims and Objective: To compare the efficacy of glycolic acid peel and intense pulsed light in the treatment of melasma. Setting: Outpatient department of Dermatology, Venerology Leprology of a tertiary health care centre with an attached medical college. Material and Methods: 60 patients of melasma were recruited in the study. Patients were randomly allocated into two groups: one group (glycolic acid 50%) and another group (IPL) with 30 patients in each group. All the participants were subjected to undergo pre-peel programme of daily application of sunscreens (day time) and 0.025% retinoic acid at bed time for two weeks in GA peel group. 4 peels were carried out at 2 weekly intervals. Four sessions of IPL were done at 3 weeks interval. MASI scoring and coloured photographs (without reavealing identity) of each patient were taken before each peel and at the end of the follow-up period i.e. 2 weeks after 4th sitting in GA peel group and 3 weeks after 4th sitting in IPL group. Side effects, if any, were also recorded. Statistical Analysis Used: SYSTAT version-12. Results: In both the groups there was constant decrease in MASI scores after each sitting as compared to pre-peel scores. However, the comparison of mean MASI scores i.e. both pre-peel and after each peel, between the two groups showed statistically significant difference (p<0.05). Local reactions, such as burning sensation and erythema during the peel were not significant with both the groups. Conclusions: Glycolic Acid (GA) peel (50%) is more efficacious&safe treatment modality in melasma compared to IPL.Keywords
Glycolic Peel, Intense Pulse Light, Melasma.- A Comparative Study of Efficacy, Safety and Relapse Rate of Three Drugs; Systemic Ketoconazole, Systemic Itraconazole and Topical Oxiconazole in the Treatment of Pityriasis Versicolor
Abstract Views :338 |
PDF Views:90
Authors
Source
MVP Journal of Medical Sciences, Vol 2, No 2 (2015), Pagination: 76-80Abstract
Aim: The aim of our study was to evaluate the efficacy, safety and relapse rate of systemic Ketoconazole, systemic Itraconazole and topical Oxiconazole in the treatment of pityriasis versicolor. Study design: 94 patients who had pityriasis versicolor were included in the study. The patients were given Ketoconazole, Itraconazole and Oxiconazole randomly and were followed up at the interval of 15 days, 1 month and 3 months for assessement of clinical and mycological cure. Results: In assessment of clinical parameters maximum improvement in scaling, pigmentation and pruritus was seen in Oxiconazole group compared to itraconazole and ketoconazole group. During the study it was observed that rate of clinical cure was maximum in Oxiconazole group (76.67%) as compared to Itraconazole (58.82%) and Ketoconazole group (46.66%). Mycological cure during visit 2 in Oxiconazole group was (83.33%), as compared to (88.2%) Itraconazole group and (88.7%) Ketoconazole group. During visit 3, mycological cure was present in 93.3% cases in Oxiconazole group, 94.1% in Itraconazole group and 93.3% in Ketoconazole group. During visit 4 mycological cure was assessed which showed 88.7% cure rate in Oxiconazole group compared to 88.2% in Itraconazole group and 88.7% in Ketoconazole group. These results suggested presence of relapse in 6.6% cases in both Oxiconazole and Ketoconazole group and 5.9% cases in Itraconazole group. There were no side effects with oxiconazole group while cases treated with ketoconazole and itraconazole had side effects like nausea and urticaria. Conclusion: According to the present study we conclude that topical Oxiconazole therapy was more effective as compared to systemic Itraconazole and Ketoconazole therapy in early improvement of scaling, pigmentation and pruritus secondary to Pityriasis versicolor with no significant side effects.Keywords
Efficacy, Itraconazole, Ketoconazole, Pityriasis Versicolor, Topical Oxiconazole.References
- Morishita N, Sei Y. Microreview of PityriasisVersicolor and Malassezia species. Micopathologica. 2006 Dec; 162(6):373-6.
- Kanwar AJ, Dipankar De. Superficial Fungal Infections. IADVL Textbook of Dermatology. R.G.Valia, Amit R.Valia (Editors). 3rd ed. Vol 1. p. 285-93.
- Giam YC, Rajan VS. Oral ketoconazole-A new treatment for tinea versicolor. Singapore Med J. 1984; 25:157-60.
- Richardson M, Warnock D. Other cutanious fungal infection. Fungal infection diagnosis and management. 3rd ed. Blackwell Publishing; p. 129.
- Jegasothy BV, Pakes GE. Oxiconazolenitrate : pharmacology, efficacy and safety of a new imidazole antifungal agent. ClinTher. 1991; 13:126-41.
- Jain VK, Aggarwal K. Comparative study of ketoconazole and itraconazole in pityriasis versicolor. Indian J Dermatol Venereol Leprol. 1999; 65:267-9.
- Bhogal CS, Singal A, Baruah MC. Comparative efficacy of ketoconazole and fluconazole in the treatment of pityriasis versicolor: a one year follow-up study. J Dermatol. 2001; 28:535-9.
- Gugnani HC. Oxiconazole in treatment of topical dermatomycoses. Current therapeutic research. 54(1):122-5.
- Maytham M, Al-Hilo, Hala K, AL-Obaidi, Ahmed Samir Al- Noaimi, Alwan AI. Therapeutic efficacy of different azole antifungal regimens in treatment of tineaversicolor. International Journal of advanced Biological Research. 2012: 2(4):766-71..
- Mohanty J, Sethi J, Sharma MK. Efficacy of Itraconazole in the treatment of PityriasisVersicolor. Indian Journal Dermatology Venereology Leprology. 2001; 67(5):240-1.
- Silva H, Gibbs D, Arguedas J. A comparison of fluconazole with Ketoconazole, Itraconazole and Clotrimazole in the treatment of patients with Pityriasisversicolor. Current Therapeutic Research. 1998; 59(4):203-14.
- Comparative Study of Efficacy of Topical Minoxidil 5% and Combination of Topical Minoxidil 5%, Topical Azelaic Acid 1.5% and Topical Tretinoin 0.01% on the Basis of Dermoscopic Analysis in Androgenetic Alopecia
Abstract Views :235 |
PDF Views:86
Authors
Source
MVP Journal of Medical Sciences, Vol 2, No 2 (2015), Pagination: 90-99Abstract
Background: Androgenetic alopecia (AGA) more commonly known as male pattern baldness affects up to 50% of men worldwide. Tretinoin prolongs anagen phase and increases percutaneous absorption of minoxidil three fold. Azelaic acid is an inhibitor of 5 alpha reductase and could be an effective agent in the treatment of androgen related pathology of human skin. Aims and Objective: 1) To study the efficacy of topical minoxidil 5% in treatment of androgenetic alopecia. 2) To study the efficacy of combination of topical minoxidil 5%, topical azelaic acid 1.5% and topical tretinoin 0.01% in treatment of androgenetic alopecia. 3) To compare the efficacy of foresaid topical preparation in treatment of androgenetic alopecia Setting: Outpatient department of Dermatology, Venerology Leprology of a tertiary health care centre with an attached medical college. Material and methods: Topical minoxidil 5 % lotion was used in 23 (50%) patients of the present study. Combination of topical minoxidil 5%, azelaic acid 1.5 % and tretinoin 0.01 % lotion was used in 23 (50 %) patients of the present study. Statistical analysis used: Epi info version 7. Results: There was statistically significant increase in hair number and thickness after treatment in both the groups. The comparison of the increase of hair number and thickness was statistically insignificant. Conclusions: Topical Minoxidil 5% is equally effective to combination of topical Minoxidil 5%, azelaic acid 1.5% and tretinoin 0.01% in treatment of androgenetic alopecia.Keywords
Androgenetic Alopecia, Azelaic Acid, Minoxidil, Tretinoin.- Study of Homologous Autoimplantation Therapy for Treatment of Multiple Warts in Patients Attending the Dermatology out Patient Department
Abstract Views :219 |
PDF Views:81
Authors
Source
MVP Journal of Medical Sciences, Vol 2, No 2 (2015), Pagination: 110-117Abstract
Introduction: Warts are benign tumours that commonly involve skin and other epithelial tissues. There is no single treatment modality that is 100% effective. In multiple warts, especially on face, palms, and soles destructive procedure are inappropriate and impractical. Homologous autoimplantation is a simple technique, which helps in inducing cell mediated response, causing clearance of warts. Aims and objectives: To evaluate the effect of homologous autoimplantation therapy in treatment of multiple warts. To study the untoward effects of this treatment. Material and methods: A total of 49 patients of viral warts were included in study. Homologous autoimplantation of wart was done and regular follow up was done to see the result. Results: Out of 49 patients, in 24 patients there was good response, 14 showed moderate response, 5 showed poor response and in 6 patients there was no response. Conclusion: Homologous autoimplantation is an easy, minimally invasive technique which clears multiple, recurrent and recalcitrant warts.Keywords
Homologous Autoimplantation, Warts.References
- Drake LA, Ceilley RI, Cornelison RL, Dobes WL, Dorner W, Goltz RW, et al. Guidelines of care for warts: Human papilloma viruses. J AM AcadDermatol. 1995 Jan; 32(1):98-103.
- Srivastava PK, Bajaj AK. Autowart injection therapy for recalcitrant warts. Indian J Dermatol. 2010 Oct-Dec; 55(4): 367-9.
- Lipke MM. An Armamentarium of Wart Treatments. Clin Med Res. 2006 Dec; 4(4):273-93.
- Sterling JC, Handfield-Jones S, Hudson PM. British Association of Dermatologists. Guidelines for the management of cutaneous warts. Br J Dermatol. 2001 Jan; 144(1):4-11.
- Androphy EJ, Lowy DR. ‘Warts’, in Klaus Wolff, Lowell A. Goldsmith, Amy S. Paller, David J. Leffell. Fitzpatrick’s Dermatology in General Medicine. 7th ed. Vol. 2. United States of America: The McGraw-Hill Companies; 2008. p. 1914-23.
- Shivkumar V, Okade R, Rajkumar V. Autoimplantation therapy for multiple warts. Indian J Dermatolvenerolleprol. 2009 Nov-Dec; 75(6):593-5.
- Viac J, Thivolet J, Hegary MR, Chardonnet Y, Dambuyant C. Comparative study of delyed hypersensitivity skin reaction and antibodies to human papilloma virus. ClinExpimmunol. 1997; 29(2):240-6.
- Nischal KC, et al. A novel modification of autoimplantation therapy for the treatment of multiple recurrent and palmoplantar warts. J Cutanaestsurg. 2012 Jan-Mar; 5(1):26-9.
- Kuykendall-Ivy TD, Johnson SM. Evidence-based review of managementof nongenital cutaneous warts. Cutis. 2003 Mar; 71(3):213-22.
- Viac J, Thivolet J, Chardonnet Y. Specific immunity in patients sufferingfrom recurring warts before and after repetitive intradermal tests withhuman papilloma virus. Br J Dermatol. 1977 Oct; 97(4):365-70.
- Venugopal SS, Murrell DF. Recalcitrant Cutaneous warts treated with recombinant quadrivalent human papilloma virus vaccine (types 6, 11, 16and 18) in a developmentally delayed, 31-year-old white man. ArchDermatol. 2010 May; 146(5):475-7.
- Kreuter A, Waterboer T, Wieland U. Regression of Cutaneous warts ina patient with WILD syndrome following recombinant quadrivalent humanpapilloma virus vaccination. Arch Dermatol. 2010 Oct; 146(10):1196-7.
- Briggaman RA, Wheeler CE Jr. Immunology of human warts. J Am Acad Dermatol. 1979 Oct; 1(4):297-304.
- A Case Control Study of Metabolic Syndrome in Psoriasis Vulgaris Patients at Tertiary Care Institute
Abstract Views :365 |
PDF Views:100
Authors
Source
MVP Journal of Medical Sciences, Vol 3, No 2 (2016), Pagination: 79-82Abstract
Background: Psoriasis is a chronic, disfiguring, inflammatory and proliferative condition of skin influenced by both genetic and environmental factors. The prevalence of psoriasis vary from 0.1% to 3% in different population1. The pathogenesis of psoriasis is interplay of various inflammatory cytokines and chemokines which play an important role in the pathogenesis of various other systemic diseases. Psoriasis has been reported to be associated with metabolic syndrome which increases the risk of Coronary Artery Disease. Aim: To study the prevalence of metabolic syndrome among patients of psoriasis vulgaris. Setting and Study Design: This is a case-control study and was conducted at the out-patient clinic of Department of Dermatology, Venereology and Leprology of a tertiary care centre. Materials and Methods: Study was approved by the Institutional ethical committee. The patients were included in two study groups. 50 patients diagnosed with psoriasis vulgaris were included as cases. Fifty age and sex matched controls were included in the control group. The detailed demographic history, duration of disease, family history and personal history was taken. Patients were assessed for severity of psoriasis using PASI score and blood sample collected was analyzed for fasting blood sugar levels and serum lipid profile. The data collected was evaluated using Chi Square test and unpaired t test. Results: Total 50 patients were included as cases and controls respectively out of which 11 (22%) were females and 39 (78%) were males. The mean age of cases and controls was 45.85 and 46.04 respectively. The mean duration of psoriasis in cases was 78.86 months. The mean PASI score was the prevalence of Metabolic Syndrome in psoriasis vulgaris was 46% in our study. Conclusion: Metabolic syndrome is a significant morbidity which predisposes the patients for Coronary Artery Disease. The patients of psoriasis vulgaris should be routinely screened for hypetension, Type II diabetes mellitus and dyslipidemias.Keywords
Dyslipidemia, Hypertension, Metabolic Syndrome, PASI Score, Psoriasis vulgarisReferences
- Pavithran K, Karunakaran M, Aparna P, Ragunatha S. Psoriasis. In: Valia RG, Valia AR, editors. Disorders of keratinization. IADVL textbook of Dermatology. 3rd ed. Reprint. Bhalani Publishing House; 2012. p. 1021–56.
- Griffiths CEM, Barker JNWN. Psoriasis. In: Tony B, Stephen B, Neil C, Christopher G, editors. Rook’s Textbook of Dermatology. 8th ed. Wiley-Blackwell; 2010. p. 20.1–20.54.
- Eckel RH. The metabolic syndrome. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J, editors. Harrison’s principles of internal medicine. 17th ed. Mc Graw Hill Publications; 2008. P. 1509–14.
- Madanagobalane S, Anandan S. Prevalence of metabolic syndrome in south Indian patients with psoriasis vulgaris and the relation between disease severity and metabolic syndrome: A hospital-based case-control study. Indian J Dermatol. 2012; 57:353–7.
- Nisa N, Qazi MA. Prevalence of metabolic syndrome in patients with psoriasis. Indian J Dermatol Venereol Leprol. 2010; 76:662–5.
- Belliappa PR, Umashankar N. Psoriasis uncovered-comorbid conditions with special reference to metabolic syndrome. Our Dermatol Online. 2014; 5(1):14–7.
- Love TJ, Qureshi AA, Karlson EW, Gelfand JM, Choi HK. Prevalence of the metabolic syndrome in psoriasis: Results from the national health and nutrition examination survey, 2003-2006. Arch Dermatol. 2011; 147:419–24.
- Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and metabolic syndrome: A systematic review and meta-analysis of observational studies. J Am Acad Dermatol. 2012; 68(4):654–62.
- Cohen AD, Gilutz H, Henkin Y, Zahger D, Shapiro J, Bonneh DY, Vardy DA. Psoriasis and the Metabolic Syndrome. Acta Derm Venereol. 2007; 87:506–9.
- Dreiher J, Weitzman D, Davidovici B, Shapiro J, Cohen AD. Psoriasis and dyslipidemia: A population based study. Acta Derm Venerol. 2008; 88:561–5.
- Khunger N, Gupta D, Ramesh V. Is psoriasis a new cutaneous marker for metabolic syndrome? A study in Indian patients. Indian J Dermatol. 2013; 58:313–4.
- A Clinical and Histopathological Correlation among Leprosy Patients (in this Post Elimination Era) Attending Tertiary Referral Centre
Abstract Views :386 |
PDF Views:133
Authors
Affiliations
1 PG Resident, Department of Dermatology, Venerology and Leprology, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik - 422003, Maharashtra, IN
2 Associate Professor, Department of Dermatology, Venerology and Leprology, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik - 422003, Maharashtra, IN
3 Professor and Head, Department of Dermatology, Venerology and Leprology, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik - 422003, Maharashtra, IN
4 Senior Resident, Department of Dermatology, Venerology and Leprology, Dr. Vasantrao Pawar Institute of Medical Sciences and Research, Nashik – 422003, Maharashtra, IN
1 PG Resident, Department of Dermatology, Venerology and Leprology, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik - 422003, Maharashtra, IN
2 Associate Professor, Department of Dermatology, Venerology and Leprology, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik - 422003, Maharashtra, IN
3 Professor and Head, Department of Dermatology, Venerology and Leprology, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik - 422003, Maharashtra, IN
4 Senior Resident, Department of Dermatology, Venerology and Leprology, Dr. Vasantrao Pawar Institute of Medical Sciences and Research, Nashik – 422003, Maharashtra, IN
Source
MVP Journal of Medical Sciences, Vol 6, No 2 (2019), Pagination: 103-108Abstract
Background: Leprosy is caused by Mycobacterium leprae, which chiefly affect skin and peripheral nerves. Leprosy expresses itself in different clinicopathological forms depending upon underlying immunity of the host. Histopathology is considered gold standard for accurate diagnosis especially in early disease, however, clinicopathological correlation is a must for appropriate diagnosis and classification of disease that will in-turn affect the treatment and overall prognosis of the patient. The present study of clinicohistopathological correlation among leprosy patients in this post elimination era was undertaken. Aims and Objectives: To study the clinical and histopathological correlation among leprosy patients. Materials and Methods: Present study consists of 54 patients of newly diagnosed leprosy cases at Department of Dermatology, Venerology and Leprology from November 2016 to October 2018. Skin punch biopsy and slit skin smear taken from patients. Histopathological examination by staining with H&E and Fite-Faraco stain for tissue AFB and Ziehl-Neelsen staining of SSS for presence of AFB. Results: In this study, 35 cases (64.81%) showed clinicohistopathological concordance and 19 cases (35.19 %) were discordant according to Ridley-Jopling spectrum. Conclusion: Histology should be performed in all suspected patients of leprosy if feasible, for exact allocation of the patient across the spectrum for accurate treatment and to identify the vulnerable patients in borderline spectrum as they are prone for reactions, neuritis and thus deformities and it also aids in achieving terminal goal of leprosy elimination.Keywords
Clinicohistopathological Concordance, Leprosy, Ridley-Jopling Classification.References
- Tan SY, Graham C. Armauer Hansen (1841-1912): Discoverer of the cause of leprosy. Singapore Med J. 2008; 49(7): 520–21.
- Browne SG. The history of leprosy. 2nd ed. In: Leprosy, Hastings RC, ed. New York: Churchill Livingstone; 1994.1–14.
- Panday AN, Tailor HJ. Clinocohistopathological correlation of leprosy. Ind J. Dermatol Venerol. Leprol. 2008; 74: 174–76. https://doi.org/10.4103/0378-6323.39723.
- Sengupta U. Leprosy: Immunology. In: Valia RG and Valia AR. IADVL Textbook and Atlas of Dermatology, 2nd edn. Mumbai. Bhalani Publishing House. 2001: 1573.
- Ridley DS, Jopling WH. Classification of leprosy according to immunity: a five group system. Int. J. Lep. 1996; 34(3): 255–77.
- Jopling WH, Mcdougall AC. Diagnostic Tests, In: Hand book of leprosy, 5th edn. CBS. 1999.60.
- Nayak SV, Shivarudrappa AS, Nagarajapa AH, Ahmed SM. Role of modified rapid AFB method in Histopathological sections of Hansen’s disease. Ind. J. Dermatol Venereol Leprol. 2003; 69: 173–74.
- Lucus SB, Ridley DS. Use of histopathology in leprosy diagnosis and research. Lep Rev. 1989; 60: 257–62. https://doi.org/10.5935/0305-7518.19890031.
- Ridley DS, Charles SK. The pathology of leprosy, In: Leprosy (Hastings). Churchill Livingstone. 1985.111.
- Ridley DS, Jopling WH. A classification for research purposes. Lepr Rev 1962; 33: 119–28. https://doi.org/10.5935/0305-7518.19620014.
- Scollard MD. Classification of leprosy: a full colour spectrum, or black and white? Int J Lepr Other Mycobact Dis. 2004; 72 (2) 166–168. https://doi.org/10.1489/1544-581X(2004)072<0166:COLAFC>2.0.CO;2.
- Gupte MD, Manickam P. Leprosy: Epidemiology. 3rd ed. In: IADVL Textbook of Dermatology, Valia RG, Valia AR, eds. Mumbai: Bhalani Publishers; 2008. 1994–2004.
- Charles K Job, Joyce Ponnaiya.Laboratory diagnosis. 1st ed. In: IAL Textbook of Leprosy, Hemanta Kumar Kar, Bhushan Kumar. New Delhi: Jaypee Publishers; 2010; 177–187.
- www.nlep.nic.in (National leprosy elimination programme website).
- Noordeen SK. The epidemiology of leprosy. 2nd ed. In: Leprosy, Hastings RC. New York: Churchill Livingstone; 1994; 15–30.
- Nitesh Mohan, Nitish Mishra, Int J Med Res Health Sci. 2013; 2(4): 887–892. https://doi.org/10.5958/j.2319-5886.2.4.142.
- Ankur Kumar, S. R. Negi, Kusum Vaishnav, A study of Clinicohistopathological correlation of leprosy in a tertiary care hospital in western district of Rajasthan. Journal of Research in Medical and Dental Science. 2014; 2(3): 43–48. https://doi.org/10.5455/jrmds.20142310.
- Bijjaragi S,V Kulkarni , KK Suresh , KR Chatura , P Kumar, Correlation of clinical and histopathological classification of Leprosy in post elimination era, Indian J Lepr. 2012; 84: 271–275.
- Nadia S, Jindal R, Ahmad S, Rawat SDS, Selvi Thamarai N, Harsh Meena, clinico pathological correlation of leprosy: a 4 years retrospective study from a tertiary referral centre in North India. Int J Med Res Health Sci. 2015; 4(2): 350–354. https://doi.org/10.5958/2319-5886.2015.00065.X.
- K L Shobha, C J Prakash, Clinico-Histopathological Study of Leprosy. International Int. J. Sci. Study. 2015; 3(1): 94–98.
- Mathur MC, Ghimire RBK, Shrestha P, Kedia SK. Clinicohistopathological Correlation in Leprosy. Kathmandu Univ Med J. 2011; 36(4): 248–51. https://doi.org/10.3126/kumj.v9i4.6338.
- K N Shivaswamy, A L Shyamprasad , T K Sumathy , C Ranganathan , Vidushi Agarwal .Clinico histopathological correlation in leprosy, Dermatol. Online J. 2012; 18 (9): 1–2.
- Giridhar M, Arora G, Lajpal K, Singh Chahal K.Clinicohistopathological concordance in leprosy - a clinical, histopathological and bacteriological study of 100 cases Indian. J. Lepr. 2012; 84(3): 217–225.
- Manandhar U, Adhikari RC, Sayami G: Clinico-Histopathological Correlation of Skin Biopsies in Leprosy. Journal of Pathology of Nepal. 2013; 3: 452–8. https://doi.org/10.3126/jpn.v3i6.8992.
- Bhatia AS, Katoch Kiran, Narayanan RB, Ramu Gopal, Mukherjee Ashok, Lavania RK: Clinical and Histopathological Correlation in the Classification of Leprosy. Int. J. Lepr. 1993; 61(3): 433–438.
- An Observational Study of Dermatological Manifestations in Patients of Chronic Renal Failure Undergoing Hemodialysis
Abstract Views :312 |
PDF Views:105
Authors
Affiliations
1 PG Resident, Department of Dermatology, Venereology and Leprology, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422002, Maharashtra, IN
2 Associate Professor, Department of Dermatology, Venereology and Leprology, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, Maharashtra, IN
3 Professor and Head, Department of Dermatology, Venereology and Leprology, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, Maharashtra, IN
4 Senior Resident, Department of Dermatology, Venerology and Leprology, Dr. Vasantrao Pawar Institute of Medical Sciences and Research, Nashik – 422003, Maharashtra, IN
1 PG Resident, Department of Dermatology, Venereology and Leprology, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422002, Maharashtra, IN
2 Associate Professor, Department of Dermatology, Venereology and Leprology, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, Maharashtra, IN
3 Professor and Head, Department of Dermatology, Venereology and Leprology, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, Maharashtra, IN
4 Senior Resident, Department of Dermatology, Venerology and Leprology, Dr. Vasantrao Pawar Institute of Medical Sciences and Research, Nashik – 422003, Maharashtra, IN
Source
MVP Journal of Medical Sciences, Vol 6, No 2 (2019), Pagination: 120–125Abstract
Background: Chronic Renal Failure (CRF) patients develop myriad of cutaneous findings. Novel cutaneous changes are being described since the introduction of hemodialysis, which prolongs the life expectancy, and thus more time for the skin changes to develop. Aims & Objectives: We aimed to evaluate the prevalence of dermatologic manifestations among the patients suffering from Chronic Renal Failure (CRF) who are on hemodialysis. Methods: 93 patients with CRF receiving hemodialysis were evaluated for skin, hair and nail changes. Results: All the enrolled patients experienced some skin problem. The most prevalent cutaneous manifestation was xerosis (54.8%), followed by pallor (21.5%), pruritus (19.35%) and dyspigmentation (18.3%). Other dermatologic manifestations included Kyrle’s disease (5.4%); fungal (5.4%), bacterial (6.5%) and viral (3.2%) infections and purpura (9.7%). Recorded nail changes were half and half nail (21%), koilonychia (39.78%), onychomycosis (1.08%), onychorrhexis (6.45%), splinter hemorrhages (1.08%), and Beau’s lines (2%). Hair changes included sparse hair (18.28%), and brittle and lustreless hair (11.83%). Oral cavity manifestations were enlarged tongue with teeth indentations (23.65%). Conclusions: CRF is associated with multiple skin, hair and nail manifestationsKeywords
Dyspigmentation, Koilonychia, Onychomycosis, Pruritus, Xerosis.References
- Udaykumar P, Balasubramanian S, Ramalingam KS, Lakshmi C, Srinivas CR, Mathew AC. Cutaneous manifestations in patients with chronic renal failure on hemodialysis. Indian J Dermatol Venereol and Lepr. 2006; 72:119–25. https://doi.org/10.4103/0378-6323.25636 PMid:16707817
- Hegab D, Mourad B, Okasha K, Rizk S. Prospective study on prevalence of dermatological changes in patients under hemodialysis in hemodialysis units in Tanta University hospitals, Egypt. Clinical, Cosmetic and Investigational Dermatology. 2014 Nov; 313–17. https://doi.org/10.2147/CCID.S70842 PMid:25419152 PMCid:PMC4235205
- Thomas R, Kanso A, Sedor JR. Chronic kidney disease and its complications. Prim Care. 2008; 35(2):329–44. https://doi.org/10.1016/j.pop.2008.01.008 PMid:18486718 PMCid:PMC2474786
- Sorour N, Saudi W, Elmasry A, Sanad E. Prevalence of cutaneous manifestations in chronic renal failure patients on regular hemodialysis: A hospital–based study. Egyptian Journal of Dermatology and Venerology. 2014; 34(1):27 https://doi.org/10.4103/1110-6530.137278
- Chanda GM, Chintagunta SR, Arakkal G. Dermatological manifestations in chronic renal failure patients with and without hemodialysis: A study at a tertiary care centre. J NTR Univ Health Sci. 2017; 6:8–14
- Singh G, Verma AK, Singh G, Singh SJ. Cutaneous changes in chronicrenal failure. Indian J Dermatol Venereol and Leprol. 1992; 58:320–22.
- Sultan MM, Mansour HH, Wahby IM, Houdery AS. Cutaneous manifestations in Egyptian Patients with Chronic Renal Failure on regular hemodialysis. J Egypt Women Dermatol Soc. 2010; 7:49–55.
- Hajheydari Z, Makhlough. Cutaneous and mucosal manifestations in patients on maintenance hemodialysis: A study of 101 patients in Sari, Iran. Iranian Journal of Kidney diseases. 2008; 2:86–90.
- Falodun O, Ogunbiyi A, Salako B,George AK. Skin changes in patients with Chronic Renal Failure. Saudi J Kidney Dis Transpl. 2011; 22(2):268272
- Kolla PK, Desai M, Pathapati RM, Valli BM, Pentyala S, Reddy GM, et al. Cutaneous manifestations in patients with Chronic Kidney Disease on maintenance Hemodialysis. ISRN Dermatology. 2012:1–4. https://doi.org/10.5402/2012/679619 PMid:22830039 PMCid:PMC3398619
- Khanna D, Singal A, Kalra OP. Comparison of cutaneous manifestations in chronic kidney disease with or without dialysis. Postgrad Med J 2010; 86:641–4. https://doi.org/10.1136/pgmj.2009.095745 PMid:21037238
- Tinea Incognito due to Over the Counter Drug Application: A Case Report
Abstract Views :142 |
PDF Views:84
Authors
Affiliations
1 Former PG Resident, Department of Dermatology, Dr. Vasantrao Pawar Medical College Hospital and Research Centre, Nashik – 422203, Maharashtra, IN
2 Professor and Head, Department of Dermatology, Dr. Vasantrao Pawar Medical College Hospital and Research Centre, Nashik – 422203, Maharashtra, IN
3 Associate Professor, Department of Dermatology, Dr. Vasantrao Pawar Medical College Hospital and Research Centre, Nashik – 422203, Maharashtra, IN
4 Assistant Professor, Department of Dermatology, Dr. Vasantrao Pawar Medical College Hospital and Research Centre, Nashik – 422203, Maharashtra, IN
1 Former PG Resident, Department of Dermatology, Dr. Vasantrao Pawar Medical College Hospital and Research Centre, Nashik – 422203, Maharashtra, IN
2 Professor and Head, Department of Dermatology, Dr. Vasantrao Pawar Medical College Hospital and Research Centre, Nashik – 422203, Maharashtra, IN
3 Associate Professor, Department of Dermatology, Dr. Vasantrao Pawar Medical College Hospital and Research Centre, Nashik – 422203, Maharashtra, IN
4 Assistant Professor, Department of Dermatology, Dr. Vasantrao Pawar Medical College Hospital and Research Centre, Nashik – 422203, Maharashtra, IN
Source
MVP Journal of Medical Sciences, Vol 8, No 2 (2021), Pagination: 321–322Abstract
Tinea incognito caused by of over the counter and overuse of topical steroids resulting in various clinical presentations making it difficult to diagnose. Now-a-days over the counter use of topical combinations containing steroids have increased. We present here a case of an adult female presented with lichenified plaque over both bottocks, abdomen and lower limbs associated with itching with history of over the counter application of topical steroid containing combination on her own. KOH mount of skin scraping confirmed the diagnosis. Treatment with systemic and topical antifungals for 6 weeks resulted into remarkable improvement.Keywords
Over the Counter Drugs, Steroids, Tinea Incognito, KOH MountReferences
- Ive FA, Marks R. Tinea incognito. Br Med J. 1968; 3: 14952. https://doi.org/10.1136/bmj.3.5611.149 PMid:5662546 PMCid:PMC1986136
- Dhaher S. Tinea incognito: Clinical perspectives of a new imitator. Dermatology Reports. 2020 Jun 25; 12(1).
- https://doi.org/10.4081/dr.2020.8323 PMid:32655844 PMCid:PMC7341072
- Feder HM. Tinea incognito misdiagnosed as erythema migrans. New Engl J Med. 2000; 343:69. https://doi.
- org/10.1056/NEJM200007063430116 PMid:10896550
- Romano C, Maritati E, Gianni C. Tinea incognito in Italy: A 15-year survey. Mycoses. 2006 Sep; 49(5):383-7. https:// doi.org/10.1111/j.1439-0507.2006.01251.x PMid:16922789
- Sardana K, Kaur R, Arora P, Goyal R, Ghunawat S. Is antifungal resistance a cause for treatment failure in dermatophytosis: A study focused on tinea corporis and cruris from a tertiary centre? Indian Dermatology Online Journal. 2018 Mar; 9(2):90. https://doi.org/10.4103/idoj.
- IDOJ_137_17 PMid:29644192 PMCid:PMC5885633